GENEVA, Oct. 30 -- AXTER THERAPEUTICS BIOPHARMACEUTICAL (TIANJIN) CO., LTD filed a patent application (CN2026/086927) for “PTPN-PROTEIN-TARGETING PROTAC DRUG AND USE THEREOF”. With publication no. WO/2026/223335, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 417/14
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....